Gustave Roussy, Europe’s leading cancer centre, is working with Axians and Dell Technologies to improve oncology research and treatment.
The institute, which takes a wholly integrated approach to research, care and teaching to treat patients living with all types of cancer, brings together 3,100 employees, 520 doctors, 1,200 carers and 950 researchers.
After having successfully implemented a number of projects – such as upgrading the IT infrastructure, managing obsolescence, driving performance and enhancing resilience – Axians France is proud to continue working with Gustave Roussy. The contract focuses on optimising data and developing a platform to virtualise and store data for the institute. Project rollout was facilitated by the choice of technology solutions that combine volume, performance and data security.
“The healthcare industry has changed considerably in recent years. Volume and performance requirements have become a central focus, so it’s crucial we adopt increasingly innovative technology. Our expertise in healthcare enabled us to respond to Gustave Roussy’s emerging tech needs and advise them as how to best implement and integrate equipment,” said Olivier Pasquet, Director for the Greater Paris region at Axians (VINCI Energies).
Gustave Roussy uses an integrated solution developed by Dell Technologies to support its current and future precision medicine initiatives. The solution combines high performance client systems with a scalable hybrid storage system, based on hyper-converged infrastructure (HCI) to provide fast data processing and access, mass storage capacity and powerful analytics capability.
“We needed to upgrade our infrastructure, make it more scalable and improve security. We were supported by our partners to successfully achieve hypercovergence, virtualise our workspaces and optimise our storage capacity,” said Jérémy Lion, Infrastructure Department Manager – DTNSI, Gustave Roussy.
Patient care and research generate large volumes of data, which require efficient and comprehensive processing, especially in very high-speed sequencing.